<DOC>
	<DOCNO>NCT00450164</DOCNO>
	<brief_summary>Controlled randomize study compare combine treatment ( nadolol endoscopic ligation ) versus nadolol associate isosorbide mononitrate prazosin accord hemodynamic response , prevention esofagic verices rebleeding .</brief_summary>
	<brief_title>Secondary Prophylaxis After Variceal Bleeding Non-Responders</brief_title>
	<detailed_description>The present prospective , randomize , open label study , parallel group , patient hemorrhage cause esofagic varix randomize two group treatment , control acute hemorrhage . All patient include receive standard medical treatment beta - blocker endoscopic ligation esofagic varix . The control group constitute patient assigned receive endoscopic ligation nadolol ( N ) . The experimental group constitute patient assigned receive treatment accord hemodynamic response . All patient include experimental group receive pharmacologic treatment nadolol combine Isosorbide Mononitrate ( MNI ) Prazosin ( PZ ) . In group practice basal hepatic hemodynamic study 4th-5th day admitance ( achieve hemodynamic stability least 48 h hemorrhage control ) second control hepatic hemodynamic study 3-4 week begin pharmacologic treatment , adjust dos . In experimental group , responder N + MNI keep treatment , nonrespondent hemodynamic study switch treatment N + PZ third hepatic hemodynamic study perform 3 4 week dosage adjustement . The randomization stratify accord degree hepatic failure measure Child-Pugh classification ( class A B versus C ) The design random avoid bias selection patient .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Hypertension , Portal</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<mesh_term>Prazosin</mesh_term>
	<mesh_term>Nadolol</mesh_term>
	<mesh_term>Isosorbide-5-mononitrate</mesh_term>
	<mesh_term>Isosorbide Dinitrate</mesh_term>
	<mesh_term>Isosorbide</mesh_term>
	<criteria>Any Patient endoscopically assess Variceal Bleeding ( esofagic gastric ) Cirrhosis Patient agreement include study onsentiment sign Any associated comorbidity life expectancy lesser 6 month Patient refusement include study . Pregnancy Failure control acute bleed Previous prophylaxis treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Variceal bleeding</keyword>
	<keyword>Secondary profilaxis</keyword>
	<keyword>Hemodynamic</keyword>
	<keyword>Portal hypertension</keyword>
</DOC>